Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.61 USD | -5.09% | +10.88% | -63.55% |
Mar. 28 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 05 | Top Midday Gainers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.55% | 35.72M | |
+33.59% | 690B | |
+26.43% | 546B | |
-5.13% | 358B | |
+18.91% | 323B | |
+4.72% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+3.91% | 161B |
- Stock Market
- Equities
- CASI Stock
- News CASI Pharmaceuticals, Inc.
- CASI Pharmaceuticals, BioInvent Dose First Patient in Trial of Combination Treatment for Non-Hodgkin's Lymphoma